News
Article
Author(s):
Cases have been confirmed in Mexico and Canada.
As of April 18, 2025, the CDC has reported a total of 800 measles cases across the nation. Although the outbreak remains most concentrated in Texas, cases have now been confirmed in at least 12 states, as well as across the borders into Mexico and Canada. This represents a 12% increase from the prior week. The outbreak has led to 2 confirmed pediatric deaths and 1 case that is still under investigation. As efforts to curb the outbreak continue, the CDC reports that cases of measles are underreported.1-4
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
“We do believe that there’s quite a large amount of cases that are not reported and underreported,” David Sugerman, MD, a senior scientist leading the CDC’s measles response, told NBC News. “In working very closely with our colleagues in Texas and in talking with families, they may mention prior cases that have recovered and never received testing or other families that may have cases and never sought treatment.”4
Measles is considered the most contagious virus on the planet, underscoring the critical need for continued prevention through vaccination. One infected person can pass the virus to 18 other people through exposure to nasal or throat secretions when an infected person coughs, sneezes, or breathes. These viral particles remain contagious in the air and on surfaces for up to 2 hours after they leave. Among unvaccinated individuals, 90% will contract measles from another infected person. In the current outbreak, 96% of the cases are among unvaccinated individuals.5,6
The measles, mumps, and rubella (MMR) vaccine is extremely effective at preventing contracting measles and led to its near eradication in 2000. With the first dose, the vaccine is 93% effective, and 97% with the second dose. These doses are typically administered at 12 to 15 months (first dose) and 4 to 6 years old (second dose). The most common adverse events (AEs) include pain where the vaccine is given, fever, a mild rash, and swollen glands in the cheeks or neck. Serious adverse events are extremely rare.7
Despite its proven safety and efficacy, the MMR vaccine continues to face resistance. Public health officials point to widespread misinformation and lingering mistrust fueled by a now-debunked 1998 study published in The Lancet that falsely linked the MMR vaccine to autism, although the study was later. The damage to public perception has persisted since then and has since been made worse by vaccine skepticism during the COVID-19 pandemic.5,6
Efforts to increase vaccination rates are ongoing. In Texas and other high-burden areas, local health departments have launched mobile vaccination clinics, school-based immunization drives, and targeted outreach to at-risk populations. The CDC has also ramped up surveillance, expanded testing access, and provided guidance to clinicians on recognizing and reporting measles cases quickly.8
The outbreak is also prompting responses beyond the United States. Health officials in Canada and Mexico are working with the CDC to monitor cross-border transmission and align public messaging. Although no formal travel advisories have been issued yet, the WHO has expressed concern over the global implications of measles resurgence and is urging countries to reinforce routine immunization programs.9
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria